Cyclophosphamide, for example, enables translocation of selected G+ bacteria to lymph nodes by disrupting the integrity of the intestinal epithelium, thereby inducing IFN-γ+IL-17+ Th cells that can slow down tumor growth (Viaud et al. 2013). Here, IL17A is linked to neoplasm.